Kindred Biosciences
KIN
#7509
Rank
โ‚น38.46 B
Marketcap
โ‚น846.03
Share price
0.11%
Change (1 day)
N/A
Change (1 year)

Revenue for Kindred Biosciences (KIN)

Revenue in 2021 (TTM): โ‚น0.58 Billion

According to Kindred Biosciences 's latest financial reports the company's current revenue is โ‚น0.72 Billion. In 2020 the company made a revenue of โ‚น3.85 Billion an increase over the revenue in the year 2019 that were of โ‚น0.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kindred Biosciences from 2019 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚น0.58 B-84.84%
2020โ‚น3.85 B885.15%
2019โ‚น0.39 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
โ‚น5.434 T 749,582.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Zoetis
ZTS
โ‚น859.47 B 118,459.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.875 T 810,334.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Phibro Animal Health
PAHC
โ‚น128.01 B 17,559.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
โ‚น23.31 B 3,115.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Petco
WOOF
โ‚น548.63 B 75,580.91%๐Ÿ‡บ๐Ÿ‡ธ USA